Medical professionals discuss COVID-19 and oncology research and COVID-19 survivors who are experiencing the long-hauler syndrome share their stories.
Part 1 of a 2-part series. Medical professionals and patient advocates discuss their experiences with postpartum depression, one of the most common medical complications during and after pregnancy.
Access the webinar here.
In this webinar, a speakers from Merck/EMD Serono, TrialScope and CISCRP discuss building a clinical trials website that engages patients and the public.
Robert Janiak, Head of Clinical Trial Transparency, Merck KGaA, Darmstadt, Germany, which operates its healthcare business as EMD Serono in the US and Canada, reviews the launch of a dedicated clinical trials website using the TrialScope Engage™ platform. Jill McNair, Senior Director, Health Communication Services for CISCRP, discusses how CISCRP obtained patient input and how that feedback guided content creation. Naor Chazam, CMO, TrialScope explains how its technology — syncing clinical trial data to the website and generating robust search functionality — helps patients find and enroll in relevant trials, and keep participants informed of study updates and results.
CISCRP hosted a webinar on October 29, 2019 to share the results of the latest 2019 Perceptions & Insights Study. Over 12,450 people (including 3,600 prior study volunteers) from around the world provided their opinions on clinical research. This latest study reveals significant new insights on patient engagement preferences in particular – such as preferences for learning about clinical trials and services which reduce burden the most, the impact of physician recommendations and involvement in clinical trials, and receptivity to emerging models of clinical trials and new technologies. Critical differences in sentiments by region, race/ethnicity and other demographic variables will also be explored, along with trends and comparisons to prior studies.
- How perceptions of clinical research have changed over the years
- Preferred patient engagement initiatives
- Ways to improve clinical research experiences
- Continued acknowledgment of the importance of clinical research, but awareness and trust less among those that have never participated
- Healthcare provider recommendations continue to be critical to increasing participation in trials
- No one size fits all when it comes to various clinical trial models (traditional vs de-centralized)
- Study summary and individual results most wanted post-participation
- Electronic consent forms viewed as easier to understand compared to paper
- Ken Getz, Founder and Board Chair at CISCRP and Deputy Director and Professor at Tufts CSDD Tufts University School of Medicine
- Annick Anderson, Director of Research Services at CISCRP
- Jasmine Benger, Senior Project Manager of Research Services at CISCRP
CISCRP and World Courier collaborated to host a webinar on September 24, 2019. This webinar examines the role of patient engagement in recruitment, retention and patient satisfaction in clinical trials.
- Patient Feedback on Clinical Trial Participation
- What do Patients Want and how can we Support Them?
- Value of Investing in Patient Engagement
- What is Direct-to-Patient (DtP) Logistics?
- DtP Case Study: Collaborative Project Setup
- What are Organizations Doing Now? What are the Next Steps?
- There is no ‘one-size fits all’ approach to patient engagement – options are key!
- Helping advance science and treatment, the ability to access information about their health and condition, and the amount of care and attention they received while enrolled are some of the top ‘likes’ among clinical trial volunteers
- Jasmine Benger, Senior Project Manager, Research Services, CISCRP
- Alex Guite, Vice President, Strategy and Services, World Courier
- Mike Sweeney, Senior Director, Patient Centric Logistics, World Courier
Archive – This webinar was presented by CISCRP on July 17, 2019.
CISCRP and the Medical Research Network (MRN) are collaborating to host an upcoming webinar, “Building Patient-Centric Trials, Putting the Patient First,” to share important information about the clinical trial process and ways to improve the trial participant experience.
Attendees will hear presentations from expert speakers Annick Anderson, Director of Research Services at CISCRP and Helena Baker, Vice President of Clinical Strategy at MRN. Annick Anderson’s presentation will include data and key takeaways from CISCRP’s Perceptions and Insights study, highlighting patient feedback and reflecting on participant needs in the clinical trial process. Helena Baker will explore patient-centric trial design and solutions available to clinical trial sites to increase efficiencies and ease the patient burden.
The agenda will include:
20-minute Presentation by Annick Anderson
20-minute Presentation by Helena Baker
15-minutes Q&A session (if necessary)
Director of Research Services at CISCRP
As the Director of Research Services at CISCRP, Annick Anderson manages the design, implementation, analysis and reporting of a variety of CISCRP research studies. She has more than 15 years of experience conducting primary and secondary research studies in the healthcare, life sciences and consumer goods industries. Prior to CISCRP, she worked at Colgate-Palmolive as a research manager. Annick holds an MBA from the Graduate School of Management at Boston University and a Bachelor of Science degree from Bryant University.
Vice President of Clinical Strategy at MRN
Helena Baker is the Vice President of Clinical Strategy at Medical Research Network. She has over 34 years’ experience in nursing and healthcare. She previously worked at Healthcare at Home, the Royal London Hospital in Whitechapel, Ferring Pharmaceuticals Ltd and St Bartholomew’s Hospital as well as acting as a healthcare analyst to the pharmaceutical industry. Helena has experience in setting up and running nursing services, working internationally across healthcare sectors and owning and running her own business.
Archive – This webinar was presented by CISCRP on October 10, 2018.
Our lives are impacted by clinical research every day. Each medication you take was proven safe and made available with the help of clinical research and the individuals who participated. But what exactly are clinical research studies? What are the safeguards in place to protect those who participate? What are the risks and benefits to evaluate whether participating is the right choice for you?
On Wednesday, October 10 we hosted a free webinar that will feature an overview presentation about the clinical research process and a panel discussion with research professionals and study volunteers. This webinar was postponed from its original intended date this past Spring.
Archive Version – this webinar was originally presented on June 15, 2017.
Informed consent is an ethical, mandatory, and fundamental principle of healthcare research. It respects the clinical trial volunteer’s authority to decide whether to participate, reviews their role and responsibilities, and highlights the risks involved. Unfortunately, 18 to 30% of patients enrolling in a trial drop out, with 13% of drop-outs due to patient misunderstanding of consent expectations or related issues.
FDA guidance and patient advocacy groups are driving adoption of electronic consent (eConsent) to make the consenting process more engaging and easier to understand for patients and caregivers. With patient recruitment costs accounting for nearly 1/3 of the total trial cost, there is a financial as well as an ethical reason to make sure patients fully understand the clinical trial process and their vital role. This webinar will review the current informed consent process and how eConsent may help to improve patient comprehension, engagement, and retention.
The presenter from CISCRP will discuss:
- The purpose of informed consent
- Current rules and regulations around the informed consent process
- Data and insights on the number of patients who drop out of studies due to lack of understanding the informed consent
The presenter from DrugDev will discuss how eConsent:
- Ensures patient understanding through multimedia education
- Improves patient retention and reduces recruitment needs
- Provides insight and metrics into how patients read and understand documents
- Improves regulatory compliance
Founder and Board Chair at CISCRP
President of DrugDev Patient Solutions
Archive Version – this webinar was originally presented by CISCRP’s Jill McNair and Annick Anderson on March 27, 2017. View a copy of the presentation using the link below.
Patient engagement is no longer just a buzzword, but rather a movement that requires innovative strategies to make meaningful impact. In this webinar, we will explore various methods and tools that can be utilized to drive patient engagement strategies. We will discuss practical approaches that can be easily integrated and implemented into any clinical research enterprise to enhance patient engagement in a truly significant way.
We will examine how Patient Advisory Boards and Patient Journey Roadmaps can be used to solicit patient input at any phase of drug development. These tools are essential for incorporating the patient voice and signaling to patients that they are valued partners in the clinical research process.
We will also discuss how returning trial results in lay language to study volunteers can be an effective tool to drive patient engagement. Patients want to know the results of the clinical trials that they have participated in, and implementing a lay language summary program into the clinical research process can have a positive impact on how patients view clinical trial participation.
- Trends in patient engagement
- The case for engaging patients as drug development partners
- The ins and outs of Patient Advisory Boards and Patient Journey Roadmaps
- Maintaining patient engagement after participation
- Leveraging lay language summaries as a patient engagement tool
- Driving culture change to embrace new patient engagement approaches
MBA, Senior Director, Patient Engagement, CISCRP
MBA, Director, Research Services, CISCRP